Invention Grant
- Patent Title: 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
-
Application No.: US15819372Application Date: 2017-11-21
-
Publication No.: US10336732B2Publication Date: 2019-07-02
- Inventor: Linghong Xie , Philip Glyn Jones , Kerry L. Spear , Noel Aaron Powell , Taleen G. Hanania , Vadim Alexandrov
- Applicant: Sunovion Pharmaceuticals Inc. , PGI Drug Discovery LLC
- Applicant Address: US MD Marlborough US NJ Paramus
- Assignee: Sunovion Pharmaceuticals Inc.,PGI Drug Discovery LLC
- Current Assignee: Sunovion Pharmaceuticals Inc.,PGI Drug Discovery LLC
- Current Assignee Address: US MD Marlborough US NJ Paramus
- Agency: Heslin, Rothenberg, Farley & Mesiti P.C.
- Main IPC: C07D405/04
- IPC: C07D405/04 ; C07D413/04 ; C07D493/04 ; C07D405/14 ; C07D413/14
Abstract:
Disclosed are compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, Ra, R1, R2, R3, R4, R6, w and n1 are defined and described herein; compositions thereof; and methods of use thereof. These compounds are useful for treating a variety of neurological and psychiatric disorders, such as those described herein.
Public/Granted literature
- US20180093974A1 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS Public/Granted day:2018-04-05
Information query
